NOTICE: Citizendium is still being set up on its newer server, treat as a beta for now; please see here for more.
Citizendium - a community developing a quality comprehensive compendium of knowledge, online and free. Click here to join and contribute—free
CZ thanks our previous donors. Donate here. Treasurer's Financial Report -- Thanks to our content contributors. --

Search results

Jump to: navigation, search

Page title matches

  • ...to as [[hybridomas]]." <ref>{{MeSH|Antibody, monoclonal}}</ref> Monoclonal antibodies have extensive applications in clinical medicine and immunochemistry. ...[World Health Organization]] is refining naming conventions for monoclonal antibodies. <ref name=WHOname>{{citation
    2 KB (244 words) - 14:00, 26 April 2014
  • ...anized. If only the constant region is modified they are called [[Chimeric monoclonal antibody|chimeric]]." <ref>{{MeSH}}</ref> Naming of humanized monoclonal antibodies is governed by [[World Health Organization]]’s [http://www.who.int/medi
    787 B (103 words) - 13:56, 26 April 2014
  • Highly specific antibodies produced in large quantity by the clones of a single hybrid cell formed i
    198 B (33 words) - 05:55, 5 September 2009
  • ...stant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab." [[National Library of Medicine]]
    411 B (60 words) - 13:46, 26 April 2014
  • Auto-populated based on [[Special:WhatLinksHere/Monoclonal antibody]]. Needs checking by a human.
    640 B (83 words) - 23:38, 11 January 2010

Page text matches

  • ...anized. If only the constant region is modified they are called [[Chimeric monoclonal antibody|chimeric]]." <ref>{{MeSH}}</ref> Naming of humanized monoclonal antibodies is governed by [[World Health Organization]]’s [http://www.who.int/medi
    787 B (103 words) - 13:56, 26 April 2014
  • ...to as [[hybridomas]]." <ref>{{MeSH|Antibody, monoclonal}}</ref> Monoclonal antibodies have extensive applications in clinical medicine and immunochemistry. ...[World Health Organization]] is refining naming conventions for monoclonal antibodies. <ref name=WHOname>{{citation
    2 KB (244 words) - 14:00, 26 April 2014
  • In [[physiology]], '''antibodies''' are "[[immunoglobulin]] molecules having a specific amino acid sequenc Antibodies include [[monoclonal antibody|monoclonal antibodies]].
    412 B (53 words) - 13:33, 26 April 2014
  • ...[[antimalarial]]s, [[penicillamine]], and [[monoclonal antibody|monoclonal antibodies]] against [[tumor necrosis factor-alpha]] and other immunochemicals
    422 B (46 words) - 00:00, 19 September 2010
  • [[Antitoxin]]s, drugs using [[monoclonal antibody|monoclonal antibodies]], etc., which directly attack or neutralize the pathogen or its effects, ...of the pathogen, as do [[antitoxin]]s or [[monoclonal antibody|monoclonal antibodies]] that kill organisms, passively add immune defensive factors, or neutral
    7 KB (1,004 words) - 15:12, 30 May 2009
  • ...plasma|plasma]], [[saliva]], or [[urine]]. Such tests may detect [[HIV]] [[antibodies]], [[antigen]]s, or [[RNA]]. In the [[United States]], a number of HIV te Nonspecific reactions, hypergammaglobulinemia, or the presence of antibodies directed to other infectious agents that may be antigenically similar to
    26 KB (3,984 words) - 12:20, 17 October 2009
  • [[Monoclonal antibody|monoclonal antibodies]] targeting [[tumor necrosis factor]] are the most recent therapy.
    2 KB (190 words) - 18:54, 25 June 2010
  • ==== Monoclonal antibodies==== * [[Cetuximab]] (IMC-C225) is a recombinant, human/mouse chimeric [[monoclonal antibody]] that binds to [[epidermal growth factor receptor]] (ErbB1, EG
    10 KB (1,363 words) - 20:18, 1 July 2010
  • ===Monoclonal antibodies=== ...BA, Blair BM, Baxter R, Gerding DN et al.| title=Treatment with monoclonal antibodies against Clostridium difficile toxins. | journal=N Engl J Med | year= 2010
    46 KB (6,252 words) - 22:10, 31 October 2013
  • ...DNA antibodies]] (dsDNA) and [[anti-Smith antibodies]] (Sm). [[Antihistone antibodies]] are elevated in drug-induced lupus. <ref>{{citation There may be antibodies to [[small nuclear ribonucleoproteins]], possibly created by [[cytomegalo
    4 KB (541 words) - 19:37, 31 July 2010
  • ====Monoclonal antibodies==== ...an option to control intravascular cytokine release induced by therapeutic antibodies".[11]
    4 KB (467 words) - 05:17, 6 February 2009
  • A [[monoclonal antibody]] used as an [[antineoplastic agent]]
    97 B (11 words) - 17:24, 17 July 2010
  • |rowspan=2 |discoveries in the chemical structure of [[antibody|antibodies]] ...e [[immune system]] and the production of [[monoclonal antibody|monoclonal antibodies]]
    20 KB (2,497 words) - 07:38, 11 December 2009
  • <noinclude>{{Subpages}}</noinclude>An antineoplastic agent that uses a [[monoclonal antibody]] to deliver radioisotopes to cancer cells
    135 B (17 words) - 05:53, 1 November 2010
  • A [[monoclonal antibody]] useful in treatment of [[HER2]]-positive metastatic [[breast c
    131 B (15 words) - 12:56, 5 February 2009
  • ...achexin or cachectin. Its inhibitors, all [[monoclonal antibody|monoclonal antibodies]]; they are immunosuppressive with attendant risks. These rather expensi
    48 KB (6,591 words) - 15:17, 18 April 2012
  • A [[antineoplastic agent]], of the [[monoclonal antibody]] class, directed against the CDw52 antigen expressed by [[lymph
    165 B (20 words) - 14:14, 5 February 2009
  • [[Cetuximab]] (IMC-C225) is a recombinant, human/mouse chimeric [[monoclonal antibody]] that binds to EGFR and may treat head and neck cancers, [[colo ...&id=19339720 | doi=10.1056/NEJMoa0805019 }} </ref> Panitumumab is also a [[monoclonal antibody]] that binds to EGFR and may treat [[colorectal cancer]].
    1 KB (208 words) - 12:56, 1 May 2010
  • ...e patients may be candidates for the drug [[trastuzumab]] (Herceptin), a [[monoclonal antibody]] that targets this protein. [[Trastuzumab]] may be used both i While monoclonal antibodies and other biologicall engineered drugs, simpler molecules continue to hav
    101 KB (14,656 words) - 16:27, 18 August 2015
  • Chimeric monoclonal antibody against the protein CD20, which is primarily found on the surfac
    204 B (30 words) - 15:52, 8 September 2009

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)